Gout: objective, indications and adherence to uratelowering therapy
Gout is a chronic systemic inflammatory tophus disease with recurrent arthritis of the peripheral joints in patients with hyperuricemia and the deposition of monosodium urate crystals in various tissues. Only 50% or less of patients receive therapy lowering serum uric acid levels to the target level...
Main Authors: | V. V. Tsurko, T. Ye. Morozova, M. A. Gromova, K. M. Krykhivskaya |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2019-03-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/2901 |
Similar Items
-
Modern paradigm of treatment of hyperuricemia and gout in comorbid patients with the development of cardio-vascular pathology
by: V. I. Mazurov, et al.
Published: (2020-12-01) -
UPDATED EULAR GUIDELINES FOR THE MANAGEMENT OF GOUT. COMMENTS ON CERTAIN ITEMS
by: M. S. Eliseev
Published: (2018-01-01) -
A rationally grounded approach to treating gout with regard to its onset and course and the presence of comorbidity according to the European League against Rheumatism (EULAR 2016) recommendations
by: V V Tsurko, et al.
Published: (2017-12-01) -
Commentaries on the updated American College of Rheumatology guidelines for the management of gout. Urate-lowering drugs (Part 1)
by: M. S. Eliseev
Published: (2020-09-01) -
Uric acid, gout and cardiovascular diseases: prospects for the use of urat-lowering medications
by: M. S. Eliseev, et al.
Published: (2019-08-01)